Tender detail

Purchase of alfapegunigalsidase

Summary

The tender concerns the purchase of alfapegunigalsidase for Sihtasutus Pärnu Haigla under a framework agreement until 31 March 2028. It is a medicines procurement, and the bidder must submit a price offer, confirm compliance with the technical specification, and take into account that the offered medicines must have the required marketing, import or use authorisation. The bid must also include the required declaration, any power of attorney if needed, and confirmation that the goods are not subject to international sanctions.

Reference number
309299-0000
Buyer
Sihtasutus Pärnu Haigla
Country
Estonia (EST)
Procedure
Open procedure
CPV
33600000 Pharmaceutical products
Deadline
2026-05-25
Status
Open
Contract subject
Supplies
Estimated value
Not published
Source
RHR

Participation requirements

Tender requirements are available in the official tender documents.

Compliance requirements

The machine-readable notice includes the standard exclusion grounds from the ESPD, including participation in a criminal organisation, corruption, fraud and terrorist offences. If any of these grounds apply, the bidder may need to provide evidence of self-cleaning measures. The notice also indicates that the exact exclusion details should be checked in the tender documents.

Qualification criteria and exclusion grounds

The bidder must be registered in the commercial register of its country of establishment, or provide a relevant certificate or a copy of the founding document if registration is not required. To trade medicines wholesale in Estonia, the bidder must hold the necessary operating licence, which the contracting authority will verify in the Medicines Agency register. The bid must include the declaration required by Annex 3, Form I, the bid validity period must be at least 3 months, and if necessary a power of attorney for representation or a joint bid power of attorney must be attached. The bidder must submit the Annex 1 price offer form with the product name, manufacturer, compliance data, unit prices and total price, and confirm that the bid complies with the tender documents and that equivalence has been explained where needed. The offered medicines must have a marketing authorisation from the Medicines Agency or the European Commission, or an import or use authorisation issued by the Medicines Agency.